• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Novartis` Prometax (rivastigmine) Receives Approval in Europe

    EMA

    Luye Pharma`s Rivastigmine Transdermal Patch Receives Market Approval in China

    PRESS RELEASE

    People often skip neurological meds when out-of-pocket costs rise

    REUTERS

    Zydus Noveltech`s Generic Rivastigmine Receives Approval in US

    FDA

    Luye Pharma receives China approval for CNS drug

    BIOSPECTRUM

    Mylan launches generic drug-delivery patch for dementia patients

    DRUG DEL BUSINESS

    Mylan Technologies Generic Rivastigmine Receives Approval In US

    FDA

    Dementia prescriptions six times higher than a decade ago

    PHARMATIMES

    Novartis, Allergan Alzheimer`s meds linked to abnormal behavior

    FIERCE PHARMA

    Generic alternative to Novartis` transdermal patch for Alzheimer`s hits the market

    FIERCE DRUG DELIVERY

    Orchid`s Generic Rivastigmine Tartrate (1.5, 3, 4.5, 6 Mg Base) Approved in US For Alzheimer

    FDA

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.